| NF-κB signaling and its relevance to the treatment of mantle cell lymphoma S Balaji, M Ahmed, E Lorence, F Yan, K Nomie, M Wang Journal of hematology & oncology 11, 1-11, 2018 | 75 | 2018 |
| Red-light running rates at five intersections by road user in Changsha, China: An observational study F Yan, B Li, W Zhang, G Hu Accident Analysis & Prevention 95, 381-386, 2016 | 70 | 2016 |
| A developmental stage-specific network approach for studying dynamic co-regulation of transcription factors and microRNAs during craniofacial development F Yan, P Jia, H Yoshioka, A Suzuki, J Iwata, Z Zhao Development 147 (24), dev192948, 2020 | 19 | 2020 |
| An integrative, genomic, transcriptomic and network-assisted study to identify genes associated with human cleft lip with or without cleft palate F Yan, Y Dai, J Iwata, Z Zhao, P Jia BMC Medical Genomics 13, 1-13, 2020 | 19 | 2020 |
| Challenges and opportunities for high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangement (double-hit lymphoma) D Zeng, A Desai, F Yan, T Gong, H Ye, M Ahmed, K Nomie, J Romaguera, ... American journal of clinical oncology 42 (3), 304-316, 2019 | 19 | 2019 |
| deCS: A Tool for Systematic Cell Type Annotations of Single-Cell RNA Sequencing Data Among Human Tissues G Pei, F Yan, LM Simon, Y Dai, P Jia, Z Zhao Genomics, Proteomics & Bioinformatics 21 (2), 370-384, 2023 | 15 | 2023 |
| Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations Y Che, Y Liu, Y Yao, HA Hill, Y Li, Q Cai, F Yan, P Jain, W Wang, L Rui, ... Blood cancer journal 13 (1), 27, 2023 | 13 | 2023 |
| scGWAS: landscape of trait-cell type associations by integrating single-cell transcriptomics-wide and genome-wide association studies P Jia, R Hu, F Yan, Y Dai, Z Zhao Genome biology 23 (1), 220, 2022 | 11 | 2022 |
| Cotargeting of BTK and MALT1 overcomes resistance to BTK inhibitors in mantle cell lymphoma VC Jiang, Y Liu, J Lian, S Huang, A Jordan, Q Cai, R Lin, F Yan, ... The Journal of clinical investigation 133 (3), 2023 | 10 | 2023 |
| EmptyNN: A neural network based on positive and unlabeled learning to remove cell-free droplets and recover lost cells in scRNA-seq data F Yan, Z Zhao, LM Simon Patterns 2 (8), 2021 | 9 | 2021 |
| DrivAER: Identification of driving transcriptional programs in single-cell RNA sequencing data LM Simon, F Yan, Z Zhao Gigascience 9 (12), giaa122, 2020 | 9 | 2020 |
| CleftGeneDB: a resource for annotating genes associated with cleft lip and cleft palate H Xu, F Yan, R Hu, A Suzuki, C Iwaya, P Jia, J Iwata, Z Zhao Science Bulletin 66 (23), 2340-2342, 2021 | 7 | 2021 |
| Spatiotemporal microRNA-gene expression network related to orofacial clefts F Yan, LM Simon, A Suzuki, C Iwaya, P Jia, J Iwata, Z Zhao Journal of Dental Research 101 (11), 1398-1407, 2022 | 6 | 2022 |
| Pirtobrutinib overcomes ibrutinib and venetoclax resistance in mantle cell lymphoma Y Liu, C Jiang, F Yan, J McIntosh, AA Jordan, Y Li, Y Che, Q Cai, W Wang, ... Blood 138, 1182, 2021 | 6 | 2021 |
| Paramount therapy for young and fit patients with mantle cell lymphoma: strategies for front-line therapy H Ye, A Desai, S Huang, D Jung, R Champlin, D Zeng, F Yan, K Nomie, ... Journal of Experimental & Clinical Cancer Research 37, 1-12, 2018 | 4 | 2018 |
| Dual targeting of CDK4/6 and Bcl-2 exhibits a potent antitumor effect on mantle cell lymphoma Y Che, Y Liu, Y Li, JM McIntosh, A Jordan, F Yan, W Wang, L Nie, HH Lee, ... Blood Advances 7 (14), 3361-3365, 2023 | 3 | 2023 |
| Pirtobrutinib and venetoclax combination overcomes resistance to targeted and CAR T-cell therapy in aggressive mantle cell lymphoma Y Liu, F Yan, VC Jiang, Y Li, Y Che, J McIntosh, A Jordan, I Hou, L Nie, ... Haematologica 108 (5), 1412-1416, 2022 | 3* | 2022 |
| Single-cell multiomics decodes regulatory programs for mouse secondary palate development F Yan, A Suzuki, C Iwaya, G Pei, X Chen, H Yoshioka, M Yu, LM Simon, ... Nature Communications 15 (1), 821, 2024 | 1 | 2024 |
| Potentiation of apoptosis in drug-resistant mantle cell lymphoma cells by MCL-1 inhibitor involves downregulation of inhibitor of apoptosis proteins Y Li, HH Lee, VC Jiang, Y Che, J McIntosh, A Jordan, J Vargas, T Zhang, ... Cell Death & Disease 14 (11), 714, 2023 | 1 | 2023 |
| Abemaciclib in combination with copanlisib to overcome therapeutic resistance in mantle cell lymphoma Y Che, Y Liu, Y Li, J McIntosh, AA Jordan, Z Chen, F Yan, W Wang, J Jin, ... Blood 138, 2253, 2021 | 1 | 2021 |
